Super-precise CRISPR tool enters US clinical trials for the first time.
Nature, 621(7980): 667-668 PMID 37723277 DOI 10.1038/d41586-023-02836-7
Abstract
This article has no abstract in PubMed.
Your browser does not allow saving data (e.g. private mode): bookmarks will be lost when the tab closes.